文献速递生殖医学

青春期前人类睾丸在化疗诱导耗竭后精原细胞的早期转录状态与标志物表达

Early transcriptional states of spermatogonia and marker expressions in the prepubertal human testis following chemotherapy-induced depletion.
PubMed 文献 · Hum Reprod · 2025-01-01

本研究利用单细胞RNA测序和免疫荧光染色,分析青春期前正常及癌症化疗后睾丸精原细胞的分化状态与标志物表达。结果显示青春期前仅存在未分化精原细胞,KIT蛋白表达与年龄正相关,ID4、FGFR3、KIT蛋白表达随烷化剂累积剂量增加而减少。

要点

  • 青春期前睾丸中仅存在未分化精原细胞,分化状态在青春期出现。
  • KIT蛋白表达与年龄正相关(P < 0.001)。
  • ID4、FGFR3、KIT蛋白表达减少与烷化剂累积剂量或精原细胞池耗竭相关。

核心结论

  • 青春期前男孩睾丸中仅存在未分化精原细胞,分化状态在青春期出现。
  • 年轻患者、接受烷化剂治疗或精原细胞池减少者,晚期精原细胞标志物蛋白表达降低。
  • 表达UTF1和PIWIL4的精原细胞亚型对化疗诱导的精原细胞池耗竭更具抵抗力,可能代表真正的储备干细胞。

研究设计与样本

  • 利用6例0-17岁健康男孩睾丸样本的单细胞RNA测序数据研究精原细胞亚群基因表达谱。
  • 通过免疫荧光染色检测14例生物库对照样本(中位年龄4.9岁,范围0.6-13.1岁)和31例青春期前癌症患儿睾丸组织样本(中位年龄6.8岁,范围0.7-13.1岁)的蛋白表达模式。

主要发现

  • 转录组分析证实青春期前睾丸生殖细胞仅由未分化精原细胞组成。
  • KIT蛋白表达与年龄呈正相关(P < 0.001)。
  • 表达ID4蛋白的精原细胞数量减少与较高CED相关(P = 0.001)。
  • 表达KIT蛋白的精原细胞数量减少与较高CED和DIE暴露相关(P = 0.005和P = 0.035)。
  • 精原细胞池耗竭(S/T Z评分 < -7 SD)与表达ID4(P = 0.033)、FGFR3(P = 0.050)和KIT(P = 0.051)蛋白的精原细胞数量减少相关。

关键数值与推荐

  • 精原细胞池耗竭定义为S/T Z评分低于-7 SD。
  • 烷化剂暴露量化为累积环磷酰胺等效剂量(CED),蒽环类药物暴露量化为累积多柔比星异等效剂量(DIE)。

临床怎么用

  • 作者认为,识别储备干细胞可能为评估青春期前和围青春期男孩生育力保存所采集睾丸组织的生育潜力提供有价值的方法。

局限性

  • 研究人群在年龄和治疗暴露方面具有异质性。
  • 无法单独评估特定癌症治疗的影响。
  • 组织可用性有限降低了研究的统计效能,且无法进行重复的双重或三重免疫荧光染色。
  • 不同精原细胞标志物表达之间的相关性只能视为指示性趋势。
  • 儿童睾丸对照组织样本以无睾丸病理报告作为正常纳入标准,但生物库中患者既往医疗治疗或睾丸体积的详细信息不可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Which spermatogonial differentiation states are present in prepubertal testes under normal conditions and following chemotherapy-induced depletion of spermatogonia in paediatric patients with cancer? SUMMARY ANSWER: Single-cell transcriptomic analysis reveals that only undifferentiated spermatogonia are present in prepubertal boys, while differentiated states emerge during puberty, with reduced protein expression of advanced spermatogonial markers observed in younger patients, those treated with alkylating agents, or those with a diminished spermatogonial pool. WHAT IS KNOWN ALREADY: Paediatric oncology treatments often involve gonadotoxic therapies that can impair spermatogonial stem cells, increasing the risk of subfertility. While five distinct spermatogonial subpopulations have been identified in adult testes via single-cell RNA sequencing, their presence in prepubertal testes of childhood cancer patients remains to be confirmed through marker protein expression. STUDY DESIGN, SIZE, DURATION: Gene expression profiles of spermatogonial subpopulations were investigated using single-cell RNA sequencing data from six testicular samples of healthy boys aged 0-17 years. Protein expression patterns were examined via immunofluorescence staining in 14 biobank control samples (median age: 4.9 years; range: 0.6-13.1 years) and in 31 prepubertal testicular tissue samples of paediatric patients with cancer (median age: 6.8 years; range: 0.7-13.1 years). PARTICIPANTS/MATERIALS, SETTING, METHODS: Gene expression profiles of UTF1 (states 0-1), ID4 (states 0-1), PIWIL4 (states 0-1), FGFR3 (states 0-2), and KIT (state 4), were analysed in testicular cells of paediatric origin obtained from our previously published open-access data source (GSE134144 and GSE120508). The protein expression of these spermatogonial subpopulation markers was evaluated by counting immunofluorescence-positive cells per analysed area. Marker expression was correlated with prior chemotherapy exposure and spermatogonia numbers. Exposure to alkylating agents was quantified as the cumulative cyclophosphamide equivalent dose (CED), and anthracycline exposure as the cumulative doxorubicin isoequivalent dose equivalents (DIE). A depleted spermatogonia pool was defined as having S/T Z-scores lower than -7 SD. MAIN RESULTS AND THE ROLE OF CHANCE: Transcriptomic analysis confirmed that germ cells in the prepubertal testis consist solely of undifferentiated spermatogonia. The expression of KIT protein, defining differentiated spermatogonia, was positively correlated with age (P < 0.001). A reduction in the number of spermatogonia expressing ID4 protein was associated with higher CED (P = 0.001), and spermatogonia expressing KIT protein with higher CED and DIE exposure (P = 0.005, and P = 0.035, respectively). A depleted spermatogonia pool (S/T Z-score <-7 SD) correlated with fewer spermatogonia expressing ID4 (P = 0.033), FGFR3 (P = 0.050), and KIT (P = 0.051) proteins. These results indicate that distinct protein expression patterns were observed following chemotherapy-induced reduction of the spermatogonial pool, with reduced expression of ID4, FGFR3, and KIT proteins. Numbers of spermatogonia positive for markers indicating more naïve, undifferentiated states, such as UTF1 and PIWIL4, did not correlate with spermatogonial pool reduction. LIMITATIONS, REASONS FOR CAUTION: The study population was heterogeneous in terms of age and treatment exposure. Moreover, the impact of specific cancer treatments could not be individually assessed. Limited tissue availability reduced the statistical power of the study, and repeated double or triple immunofluorescence staining could not be performed. As a result, the correlations between the expression of different spermatogonial markers can only be considered indicative trends. Child testicular control tissue samples were considered normal for inclusion if no testicular pathology was reported. However, detailed information on prior medical treatments or testicular volumes for the patients in this biobank was unavailable. WIDER IMPLICATIONS OF THE FINDINGS: Our observations suggest that alkylating agents have dose-dependent effects on all spermatogonial subpopulations. However, spermatogonial subtypes expressing the protein markers UTF1 and PIWIL4 were more resistant to chemotherapy-induced depletion of the spermatogonial pool, potentially representing true reserve stem cells. The identification of reserve stem cells could provide a valuable method for evaluating the fertility potential of testicular tissue collected for fertility preservation in prepubertal and peripubertal boys. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the Swedish Childhood Cancer Fund (PR2019-0123; PR2022-0115; TJ2020-0023) (J.-B.S.), Finnish Cancer Society (K.J.), Finnish Foundation for Paediatric Research (K.J.), Swedish Research Council (2018-03094; 2021-02107) (J.-B.S.), and Birgitta and Carl-Axel Rydbeck's Research Grant for Paediatric Research (2020-00348; 2020-00335; 2021-00073; 2022-00317, 2024-00255) (J.-B.S., K.J.). Y.C. and Y.Y. received a scholarship from the Chinese Scholarship Council. J.S. was supported by a grant from Mary Béves Foundation for Childhood Cancer Research. H.B.O. was supported by the Sultan Qaboos University in Oman. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ba Omar H, Stevens J, Haavisto A, et al. Early transcriptional states of spermatogonia and marker expressions in the prepubertal human testis following chemotherapy-induced depletion. Hum Reprod. 2025. PMID: 40482072. doi:10.1093/humrep/deaf103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。